- Home
- MVBF vs INBX Comparison
MVBF vs INBX Comparison
Compare MVBF & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVBF
- INBX
- Stock Information
- Founded
- MVBF 1997
- INBX 2010
- Country
- MVBF United States
- INBX United States
- Employees
- MVBF 445
- INBX N/A
- Industry
- MVBF Major Banks
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- MVBF Finance
- INBX Health Care
- Exchange
- MVBF Nasdaq
- INBX Nasdaq
- Market Cap
- MVBF 242.5M
- INBX 237.5M
- IPO Year
- MVBF N/A
- INBX 2020
- Fundamental
- Price
- MVBF $18.76
- INBX $14.76
- Analyst Decision
- MVBF Buy
- INBX Hold
- Analyst Count
- MVBF 2
- INBX 1
- Target Price
- MVBF $27.00
- INBX N/A
- AVG Volume (30 Days)
- MVBF 27.0K
- INBX 118.3K
- Earning Date
- MVBF 10-24-2024
- INBX 08-13-2024
- Dividend Yield
- MVBF 3.63%
- INBX N/A
- EPS Growth
- MVBF N/A
- INBX N/A
- EPS
- MVBF 1.56
- INBX 118.83
- Revenue
- MVBF $143,783,000.00
- INBX $1,687,000.00
- Revenue This Year
- MVBF N/A
- INBX N/A
- Revenue Next Year
- MVBF $8.72
- INBX N/A
- P/E Ratio
- MVBF $12.03
- INBX $0.12
- Revenue Growth
- MVBF 5.85
- INBX 24.26
- 52 Week Low
- MVBF $17.51
- INBX $10.80
- 52 Week High
- MVBF $25.24
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- MVBF 39.17
- INBX 44.24
- Support Level
- MVBF $18.40
- INBX $15.11
- Resistance Level
- MVBF $19.44
- INBX $15.91
- Average True Range (ATR)
- MVBF 0.48
- INBX 0.64
- MACD
- MVBF -0.09
- INBX -0.24
- Stochastic Oscillator
- MVBF 12.33
- INBX 1.62
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides community banking, mortgage banking, insurance and wealth management services to individuals and corporate clients in the Mid-Atlantic region. The Bank offers its customers various products, such as checking accounts, negotiable order of withdrawal (NOW) accounts, money market and savings accounts, time certificates of deposit, commercial, installment, commercial real estate and residential real estate mortgage loans, debit cards, and safe deposit rental facilities. MVB has three reportable segments: CoRe banking; mortgage banking and the financial holding company. It generates majority of its revenues from its CoRe banking segment.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.